The Song of the Cell: How a Cancer Doctor Explains What a Cell Actually Is

The Song of the Cell: An Exploration of Medicine and the New Human is a work of popular science published in 2022. Its author, Siddhartha Mukherjee, is a practicing oncologist and cancer researcher, and is already known for The Emperor of All Maladies, his earlier, Pulitzer Prize-winning history of cancer.

This later book is not a cancer history. Its subject is the cell itself: what a cell is, how the discipline of cell biology developed, and how understanding cells has reshaped medicine across many diseases, cancer among them.

The book moves between historical narrative, laboratory science and Mukherjee's own clinical experience as an oncologist. Cancer recurs throughout not as the book's central subject but as one of the clearest illustrations of what happens when a cell's normal controls fail, alongside sections on neurons, immune cells, stem cells and reproductive cells.

It assumes an interested general reader rather than a scientist, but it does not simplify the biology. Readers who want a plain description of what a cancer cell actually is, mechanistically, will get one, embedded in a much larger argument about the cell as the basic unit of medicine.

The book is organized into parts built around cell types and functions rather than diseases. Sections address the history of cell theory itself, then move through blood cells and immunity, neurons and the brain, stem cells and regeneration, and reproductive and embryonic cells.

Cancer material appears throughout rather than in one contained section. Discussion of cancer cells appears where the book addresses what happens when a cell's growth signals go wrong, and again where it covers cell-based cancer treatments, including CAR T-cell therapy, a treatment developed by engineering a patient's own immune cells to recognize and destroy cancer cells.

There is no patient case built around one person's cancer diagnosis, in the way a memoir would have one. Mukherjee draws on patients he has treated as an oncologist, but the book's structure is organized around the science, not around any single illness story.

The book includes extensive notes and a bibliography, reflecting its grounding in the scientific and historical literature Mukherjee draws on, rather than personal narrative alone.

The book's strength is explanatory. It takes genuinely difficult cell biology and lays it out for a reader with no scientific background, without removing the substance.

Its treatment of cancer cell biology in particular benefits from being written by a working oncologist. The parts of the book describing what makes a cancer cell behave differently from a normal cell, and how modern treatments like immunotherapy exploit cell biology directly, carry the authority of someone who has applied this knowledge in patient care, not only studied it as history.

The historical sections are also strong. The book traces cell theory from its origins in microscopy through the development of modern molecular biology, giving context for why cell-based treatments like CAR T-cell therapy represent a genuinely new category of medicine rather than an incremental step.

The book was written and published in 2022, and cell-based cancer treatment is one of the fastest-moving areas of oncology. Specific drugs, trial results and approval statuses described in the book will have moved on since publication, in both directions: some experimental approaches described as promising have since been approved for wider use, and some have not advanced as expected.

The book is a work of science writing, not a clinical reference. It does not carry treatment guidance, dosing information or eligibility criteria for any therapy it discusses, and it should not be read as a substitute for information from a person's own oncology team about what is currently available for their specific cancer.

Because cancer appears throughout the book rather than in one section, a reader looking specifically for cancer content will need to read more of the book than its title might suggest, to assemble the full picture.

The book discusses cell-based cancer treatment as a genuinely new therapeutic category, distinct from older approaches like chemotherapy and radiation that target dividing cells generally rather than specific molecular or cellular features.

NCI's own current overview, "Types of Cancer Treatment," lists the same broad categories a reader of the book would recognize: chemotherapy, which works by killing or stopping the growth of cancer and other fast-growing cells; targeted therapy, aimed at specific changes in cancer cells that help them grow and spread; immunotherapy, described as helping a patient's own immune system fight cancer; along with radiation therapy, surgery, hormone therapy and stem cell transplant.

NCI's page on what cancer is at the cellular level covers the same biological picture the book explains at greater length. NCI describes cancer as arising from an accumulation of mutations across three types of genes: proto-oncogenes, which can drive uncontrolled growth when overactive; tumor suppressor genes, which normally restrain growth; and DNA repair genes, which fix damaged DNA. NCI also lists cellular hallmarks of cancer cells that match the book's descriptions closely: growth without external growth signals, invasion of nearby tissue, recruitment of blood vessels to feed the tumor, and evasion of immune detection.

NCI describes the progression some tissues take toward cancer in stages: hyperplasia, where cells are more numerous but still normal-looking; dysplasia, where cells look abnormal but have not invaded nearby tissue; and cancer itself, once cells invade. That staged model is consistent with the cell-biology framing the book uses throughout.

For a plain-language account of what cancer is written directly for patients rather than general readers, breast cancer screening and the broader NCI material it draws on cover the clinical application of the same biology this book explains historically and scientifically. For the symptom side of that same biology, when a cell's abnormal growth first becomes noticeable to a patient, see cancer symptoms. Readers wanting the deeper molecular detail behind this book's science can also see the biology of cancer, the university-level textbook this book's science ultimately draws on.

Readers who know Mukherjee's earlier work, The Emperor of All Maladies, will notice a difference in approach. That book told cancer's history as a sustained narrative, organized around the disease itself and the people who studied and lived with it across a century. The Song of the Cell instead organizes its material around the cell as the basic unit, with cancer as one recurring case study among several diseases, including autoimmune conditions, degenerative neurological disease, and infections, that Mukherjee uses to illustrate how cell biology has reshaped what doctors can do. A reader coming to this book expecting another cancer-centered narrative should adjust that expectation; cancer is present throughout but shares the stage with cell biology's other major medical applications, including gene therapy, organ transplantation, and stem cell medicine.

That structural choice has a real payoff for a reader specifically interested in cancer, because it places cancer cell biology in context next to the immune cells that immunotherapy recruits, and next to the stem cells that some transplant-based cancer treatments depend on. Understanding a cancer cell in isolation is useful; understanding it alongside the immune and stem cells modern treatment increasingly manipulates gives a fuller picture of why cell-based cancer therapy works the way it does.

The book received a generally positive critical reception on publication, with reviewers noting both its ambition, covering the whole of cell biology in a single volume, and the risk that ambition carries: a book this broad inevitably moves faster through some material than a reader hoping for depth on one specific topic, cancer included, might want. That tradeoff is worth naming directly for a reader deciding whether to pick this book up specifically for its cancer content, rather than for its broader survey of cell biology.

Compared with The Emperor of All Maladies, which remains the more focused and more commonly recommended starting point for a reader whose primary interest is cancer specifically, The Song of the Cell rewards a reader who wants cancer situated within the wider landscape of what cell biology has made possible in medicine generally, including treatments for diseases that have nothing to do with cancer. Both books share Mukherjee's central skill, translating primary scientific literature into narrative nonfiction without discarding its substance, and a reader who found one useful is likely to find the other useful as well, for a related but distinct purpose.

This book suits a reader who wants to understand cancer, and medicine generally, at the level of the cell, and who has the patience for a long, densely sourced work of science writing. It rewards readers already comfortable with The Emperor of All Maladies or similar science books.

It does not suit a reader who wants immediate, actionable information about their own diagnosis or treatment options. It is not organized as a reference and does not answer "what does this mean for me" questions. A reader in that position is better served starting with material written directly for patients, such as NCI's own disease-specific pages, and returning to this book afterward if the underlying biology remains of interest.

Cancer Explained is free and ad-free, and you can support this work if it helped.

• Wikipedia — The Song of the Cell
• NCI — What Is Cancer?
• NCI — Types of Cancer Treatment

This page discusses The Song of the Cell for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care.